• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 3.39% Nasdaq Down 4.12%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    3.07 Down 0.07(2.23%) Jun 24, 4:00PM EDT
    |After Hours : 3.07 0.00 (0.00%) Jun 24, 4:47PM EDT
    Prev Close:3.14
    Open:2.99
    Bid:3.00 x 1500
    Ask:3.15 x 600
    1y Target Est:3.75
    Beta:0.716022
    Earnings Date:Aug 3 - Aug 8 (Est.)
    Day's Range:2.99 - 3.08
    52wk Range:2.58 - 6.63
    Volume:2,320,112
    Avg Vol (3m):1,477,840
    Market Cap:508.21M
    P/E (ttm):1.66
    EPS (ttm):1.85
    Div & Yield:0.20 (6.37%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PDLI

    Comparison

    Symbol% ChgMkt Cap
    PDLIDown 2.23%508.21M
    AMGNDown 3.82%110.02B
    XOMADown 7.90%62.84M
    SGENDown 6.19%5.27B

    Key Statistics

    Forward P/E (1 yr):51.17
    P/S (ttm):1.08
    Ex-Dividend Date:02-Jun-16

    Analysts

    Annual EPS Est (Dec-16) :0.45
    Quarterly EPS Est (Jun-16) :0.08
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.50

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback